An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

NCT00813202 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Decompensation
Congestive Heart Failure

Interventions

DRUG: Nesiritide

Sponsor

Xian-Janssen Pharmaceutical Ltd.